abrdn Life Sciences Investors
Research abrdn Life Sciences Investors (HQL) on Bullrun: dividend yield 10.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHQL
- ExchangeNYSE
- CountryUnited States
- SectorFinancial Services
- IndustryAsset Management
- CurrencyUSD
- Dividend yield10.4%
- Financial periodQ1 2026
Valuation Snapshot
dividend yield is 10.4%.
Peer valuation comparison
Latest dividend yield is 10.39% versus a Financial Services sector median of 3.86% (169.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | n/a | n/a | 10.3% | 2.24 |
| 2025 | 2025-12-31 | n/a | n/a | 10.8% | 1.82 |
| 2024 | 2024-12-31 | n/a | n/a | 14.2% | 1.86 |
| 2023 | 2023-12-29 | n/a | n/a | 9.4% | 1.27 |
| 2022 | 2022-12-30 | n/a | n/a | 9.6% | 1.36 |
| 2021 | 2021-12-31 | n/a | n/a | 8.8% | 1.69 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.24 USD, yield 10.4%.
About abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Related stock research
Other Financial Services stocks
Frequently asked questions
Does abrdn Life Sciences Investors pay a dividend?
abrdn Life Sciences Investors has a dividend yield of 10.4%.
What does abrdn Life Sciences Investors do?
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.